Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950123-09-050607
Filing Date
2009-10-15
Accepted
2009-10-15 15:00:21
Documents
2
Period of Report
2009-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A y02395a1e8vkza.htm 8-K/A 9347
2 EX-99.1 y02395a1exv99w1.htm EX-99.1 10818
  Complete submission text file 0000950123-09-050607.txt   21910
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33357 | Film No.: 091121290
SIC: 2836 Biological Products, (No Diagnostic Substances)